Studies on the inhibition of the human 2-oxoglutarate dependent oxygenase JMJD6, which is a cancer target, by 2-oxoglutarate mimics / competitors, including human drugs, drug candidates, and metabolites relevant to cancer are described. JMJD6 assays employed NMR to monitor inhibitor binding and use of mass spectrometry to monitor JMJD6-catalysed lysine hydroxylation. Notably, some clinically applied prolyl hydroxylase inhibitors also inhibit JMJD6. The results will help enable the development of inhibitors selective for human oxygenases, including JMJD6.
CITATION STYLE
Islam, M. S., Thinnes, C. C., Holt-Martyn, J. P., Chowdhury, R., McDonough, M. A., & Schofield, C. J. (2022). Inhibition of JMJD6 by 2-Oxoglutarate Mimics. ChemMedChem, 17(1). https://doi.org/10.1002/cmdc.202100398
Mendeley helps you to discover research relevant for your work.